Adverse childhood experiences and health-related quality of life among women undergoing hysterectomy for uterine leiomyoma - 20/07/22
![](/templates/common/images/mail.png)
Plan
A.A.H. has provided consulting services to AbbVie, Allergan, Bayer, Myovant Sciences, MD Stem Cells, Novartis, and ObsEva. In addition, A.A.H. holds a patent for Methods for Novel Diagnostics and Therapeutics for Uterine Sarcoma (US patent number 9,790,562 B2). The authors report no conflict of interest. |
|
This work was supported by the National Institute of Child Health and Development (grant number R21HD096248), the National Center for Advancing Translational Sciences (grant numbers UL1TR001876 and KL2TR001877), The George Washington University Milken School of Public Health, and The George Washington University Office of the Vice President for Research (Cross-Disciplinary Research Fund). The content is solely the responsibility of the authors and does not necessarily represent the official views of any of the funding agencies. |
Vol 227 - N° 2
P. 351 - août 2022 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?